| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183045 Removal of adenine during a pathogen reduction process in whole blood or red blood cell by dilution |
| 02/22/2007 | WO2007021529A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 02/22/2007 | WO2007020917A1 Agent for enhancing and prolonging utrophin production and processed food comprising the same |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007019932A1 Food product and fortification system therefor |
| 02/22/2007 | WO2006088741A3 Procoagulants based on metal-chelating lipids |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043087 Compounds exhibiting thrombopoietin receptor agonism |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042964 Compositions and methods for modulating connexin hemichannels |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042937 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 02/22/2007 | US20070042416 Dendritic Enriched Secreted Lymphocyte Activation Molecule |
| 02/22/2007 | US20070041978 Bispecific antibody substituting for functional proteins |
| 02/22/2007 | US20070041970 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 02/22/2007 | US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 02/22/2007 | CA2619214A1 Factor xa inhibitor inclusion complex with cyclodextrin |
| 02/22/2007 | CA2619145A1 Use of choline to prevent thrombosis associated with total parenteral nutrition |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2617372A1 Substituted indoles and use thereof |
| 02/21/2007 | EP1754718A2 Inactivation resistant factor VIII |
| 02/21/2007 | EP1754714A1 cyclic peptide derivatives as inhibitors of integrin alpha v beta 6 |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1520018B1 Process for producing a virus-inactivated thrombin preparation |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1414316B1 Nutritional composition preventing bacterial overgrowth |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP0942996B8 Thrombolytic agents with antithrombotic activity |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918124A New pyridin-2-one compounds useful as inhibitors of thrombin |
| 02/21/2007 | CN1917888A Solid formulation for dialysis and process for producing the same |
| 02/21/2007 | CN1916020A Peptide antiangiogenic drugs |
| 02/21/2007 | CN1915986A High purified tanshinone óÄA sodium sulfonate, fabricating method, and preparation |
| 02/21/2007 | CN1915392A Medication of medical broth for treating frequent nosebleed, and preparation method |
| 02/21/2007 | CN1915389A Medication of medical broth for treating nosebleed, and preparation method |
| 02/21/2007 | CN1915386A Medication of medical broth for treating nosebleed in excessive heat type of the lung channel, and preparation method |
| 02/21/2007 | CN1915384A Medication of medical broth for treating common nosebleed, and preparation method |
| 02/21/2007 | CN1915380A Medication of medical broth for treating nosebleed in type of hyperactivity of fire due to yin deficiency, and preparation method |
| 02/21/2007 | CN1915365A Medication of medical broth for treating nosebleed in difficult hemostasis type, and preparation method |
| 02/21/2007 | CN1915345A External preparation of Chinese traditional medicine for improving ascites due to cirrhosis, and preparation method |
| 02/21/2007 | CN1915320A Medicinal food for treating nosebleed, and preparation method |
| 02/21/2007 | CN1915318A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915317A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915316A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915306A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915305A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915304A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915302A Medication of medical broth for treating damp-heat type nosebleed, and preparation method |
| 02/21/2007 | CN1915301A Drop pills of corydalis tuber, and preparation method |
| 02/21/2007 | CN1915295A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915294A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915293A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915287A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915286A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915285A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915283A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915282A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915281A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915279A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915278A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915277A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915275A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915274A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915273A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915272A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915271A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915270A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915269A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915268A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915267A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915266A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915265A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915264A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915263A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915261A Preparation of 'thrombosis through' capsule, technique and adaptive disease |
| 02/21/2007 | CN1915259A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915258A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915257A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915256A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915255A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915254A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915251A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915250A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915249A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915246A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915245A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915237A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1301268C Thrombus-resolving and anticoagulation double function fusion protein and use thereof |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |